RDS

RDS is a developer of wearable sensor devices for monitoring cardiac health. The company develops the MultiSense device, a lightweight e-health patch that enables real-time transfer of cardiac and respiratory vital information. The device contains five embedded sensors that measure vital sign parameters including heart rate, respiratory rate, and oxygen saturation. It uses proprietary technology to collect chronic information from multiple sensors, enabling continuous remote patient monitoring for cardiac and vascular conditions. Founded in 2020 and headquartered in Strasbourg, France, RDS has raised approximately 28 million at the Series A stage with investors including Bpifrance, MACSF, Capital Grand Est, Critical Path Ventures, and SEMIA.

Wearable Technology > Health and Wellness Devices > Cardiac,

Disease Self Management > Cardiac and Vascular Disorders > Monitoring > Heart Health > Device > Wearable,

Healthcare IT > Value Based Care > Remote Monitoring > Hardware > Cardiology,

Cardiac and Vascular Disorders > Medical Devices > Monitoring Devices > Vital Signs > Clinic Based